News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine     6/22/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation     6/22/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals     6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research     6/21/2017
More Deaths Lead Seattle Genetics (SGEN) to Discontinue Phase III Leukemia Study     6/21/2017
BIO2017: Ann Romney Shares Journey Through MS Treatments, Founding of Neurological Research Center     6/21/2017
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles     6/21/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy     6/20/2017
Inovio Pharma (INO) CEO Forging Multiple Deals, Expanding Pipeline and Adding 100 New Jobs     6/20/2017
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen     6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer     6/19/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments     6/16/2017
Epizyme (EPZM) Falls as Investors Take in Disappointing Phase II Data     6/16/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics     6/15/2017

News from Around the Web
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Artificial Intelligence Helps Improve MRI Imaging Of Strokes, MIT Study Reveals     6/22/2017
Vanda (VNDA): Several Catalysts Coming Up     6/21/2017
Alzheimer's Drug Leads UBS To Upgrade Biogen (BIIB)     6/21/2017
Neuron Transistor Behaves Like A Brain Neuron, Nanyang Technological University Study Reveals     6/21/2017
3 Must-Covet Cancer Biotech Stocks     6/20/2017
How Upcoming Mystic Data Will Be AstraZeneca PLC (AZN) CEO's Biggest Test     6/20/2017
How Microsoft's HoloLens Can Reduce The Time You Are On The Operating Table     6/20/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
New Three-In-One Blood Test Opens Door To Precision Medicine For Prostate Cancer, The Institute of Cancer Research Study Reveals     6/19/2017
Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing, USC Alzheimer's Therapeutic Research Institute (ATRI) Study Reveals     6/16/2017
Modeling The Brain With 'Lego Bricks' University of Luxembourg Reveals     6/16/2017
A Mechanical Trigger For Toxic Tumor Therapy, Harvard Medical School Study     6/16/2017
Reproducing A Retinal Disease On A Chip, Tohoku University Study Reveals     6/16/2017
Why Mylan (MYL)'s EpiPen Reign Could Finally be Over     6/16/2017

Press Releases
Indivior Presents Results From The Phase III Pivotal Study Of RBP-6000 Buprenorphine Monthly Depot For The Treatment Of Opioid Use Disorder     6/22/2017
Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation     6/22/2017
Surprise: Novartis AG (NVS) Heart Drug Wows in Late-Stage Study     6/22/2017
Zealand Pharma  (ZEAL.CO) Release: Phase IIa Trial Results Support Development Of Dasiglucagon In The ILet Pump System For Type 1 Diabetes     6/22/2017
Kamada (KMDA) WIthdraws MAA For Inhaled Alpha-1 Antitrypsin     6/22/2017
pSivida (PSDV) Submits Marketing Authorization Application (MAA) For Approval Of Durasert Three-Year Treatment For Posterior Segment Uveitis In The European Union     6/22/2017
DURECT (DRRX) Completes Enrollment In PERSIST, Phase III Trial For POSIMIR     6/22/2017
Minerva Neurosciences (NERV) Announces Completion Of Bridging Study To Select Improved Formulation Of MIN-101 For Use In Phase III Trial For The Treatment Of Negative Symptoms In Patients With Schizophrenia     6/22/2017
Zogenix (ZGNX) Receives Orphan Drug Designation From FDA For ZX008 In Treatment Of Lennox Gastaut Syndrome     6/22/2017
Opko Health (OPK) Announces KDIGO Clinical Practice Guideline Update On CKD-MBD     6/22/2017
Otonomy (OTIC) Announces Successful End-Of-Phase II Review By FDA For OTIPRIO In Acute Otitis Media With Tympanostomy Tubes     6/22/2017
FibroGen (FGEN) Granted Orphan Drug Designation For Pamrevlumab In The Treatment Of Pancreatic Cancer     6/22/2017
Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation For Omaveloxolone For The Treatment Of Friedreich’s Ataxia     6/22/2017
Herantis Pharma's Lymfactin Study Advances To Last Patient Cohort, Company Announces Initial Plans For Continued Development     6/22/2017
BioPharmX To Present Phase IIb Clinical Trial Acne Data At Alabama Dermatology Society Summer Symposium     6/22/2017

//-->